Clinical trial Recruiting at 2 sites Interventional Ages 14 and up

Right-sided ablation to prevent fainting episodes

Official title: Cardio-Neuromodulation in Humans, 3th Study

Run by Imelda Hospital, Bonheiden · NCT04755101 · Data updated 2026-11-12

This study is testing if a new procedure that targets a specific area in the heart can help people with neurally mediated syncope (fainting) have fewer fainting episodes compared to those who receive a placebo.

Quick facts

Study typeInterventional
Ages14 Years and up
SexAll
Enrollment110 (estimated)
SponsorImelda Hospital, Bonheiden
Academic / other
Locations3 sites (Bonheiden and 2 other locations)
StatusRecruiting
StartedMarch 24, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedApril 24, 2025
Trial IDNCT04755101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with a history of recurrent syncope and a positive tilt table test indicating a cardioinhibitory or mixed response.

Probably not a fit

Patients with syncope due to non-cardiac diseases or those with severe heart conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, double-blind, randomized trial investigates the efficacy and safety of a CT-guided, right-sided ablation of the anterior ganglionated plexus in patients with neurally mediated syncope (NMS). The study aims to determine if this targeted ablation can reduce the recurrence of syncope episodes compared to a sham control group. Participants will undergo assessments of syncope burden and quality of life at multiple follow-up points, and the procedure involves electro-anatomical mapping and pharmacological evaluation. Two-thirds of the participants will receive the active treatment while one-third will receive a placebo.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the frequency of fainting episodes in patients with neurally mediated syncope.

How similar studies have gone: Previous studies on cardioneuroablation have shown promising results, indicating that this approach may be effective, although this specific method is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients must be in sinus rhythm and have ≥3 syncopes during the last 18 months\* and a previous positive tilt table test (TTT) with a cardioinhibitory or mixed response (VASIS I, IIA or IIB classification).

  \* syncopes occurring during TTT are not taken into account
* Patients have a 'preserved cholinergic SN reserve', defined as ≥20% sinus heart rate increment during a pharmacological test with atropine.

Exclusion Criteria:

* \<14 years age
* Any unstable medical condition, life expectancy \<12 months
* Inability to provide consent or undergo follow-up
* Syncope due to a non-cardiac disease or due to an advanced neuropathy
* Moderate to severe valvular or subvalvular aortic stenosis or mitral stenosis
* Overt heart failure or left ventricular ejection fraction \<45%
* Current pregnancy
* Chronotropic negative medications unless judged mandatory
* 4 g amiodarone intake during the 2 months preceding enrollment
* Alternating RBBB and LBBB, HV interval \>70 ms
* LBBB, bifascicular block (RBBB + LAHB, RBBB + LPHB)
* PR interval permanently \>240 ms
* Pacemaker or automated implantable cardioverter defibrillator device
* Permanent AF, PAF or electrical cardioversion during the last 6 months
* Channelopathy
* Tilt table test with VASIS III response or with VASIS II response and AV-Block

Where it's running

  • Imeldaziekenhuis
    Bonheiden, Belgium
    Recruiting
  • Universitair Ziekenhuis Gasthuisberg
    Leuven, Belgium
    Recruiting
  • Algemeen Ziekenhuis Sint Jan
    Bruges, Belgium
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.